Gynecologic & Sexual Health

STI management, preventive screenings, inclusive care, and more
Showing 10-17 of 97 results

Gender affirming hormone therapy, impacts on fertility, and future family formation

What providers need to know about family building for transgender and gender-nonbinary people beginning gender affirming hormone therapy.

Clinical scenario: Emergency contraception (EC) for transgender or gender nonbinary (TGNB) patients

A 19 year-old patient (he/him) comes to your emergency department in the early morning. He is seeking HIV post-exposure prophylaxis (PEP) following unprotected sex with a male partner the night before. During intake, he discloses that he is transgender and was assigned female at birth (AFAB). He is amenorrheic as a result of testosterone use for gender-affirming hormone therapy. At your facility, cisgender women seeking PEP are also offered EC.

Research roundup: May 2025 edition

Cancer and contraception, menstrual cups and IUD displacement, vaginal microbiome and contraceptives, OTC birth control knowledge gaps, early medication abortion follow-up

Excellent care for LGBTQ patients

Here's how to be part of the solution when it comes to the health disparities LGBTQ people face.

Research roundup: April 2025 edition

Infection prevention after abortion, estetrol in oral contraceptives, postpartum implant placement and breastfeeding, SAHM position statements

DoxyPEP: What providers need to know

DoxyPEP is an emerging evidence-based, low-cost tool for STI prevention. Here's what you need to know.

Research roundup: March 2025 edition

Partner treatment for BV, pain and bleeding experiences during first-trimester abortion, interest in Rh testing and treatment for telehealth medication abortion.

Research roundup: February 2025 edition

Double dosing UPA for EC not needed for BMI > 30, postpartum implant placement and milk supply, mifepristone to increase efficacy of medication management of EPL.
  • Previous
  • 1
  • 2(current)
  • 3
  • 4
  • 5
  • Next